These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


543 related items for PubMed ID: 12643641

  • 1. Estrogenic activity in white and red wine extracts.
    Klinge CM, Risinger KE, Watts MB, Beck V, Eder R, Jungbauer A.
    J Agric Food Chem; 2003 Mar 26; 51(7):1850-7. PubMed ID: 12643641
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM.
    Endocrinology; 2000 Oct 26; 141(10):3657-67. PubMed ID: 11014220
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner.
    Ramsey TL, Risinger KE, Jernigan SC, Mattingly KA, Klinge CM.
    Endocrinology; 2004 Jan 01; 145(1):149-60. PubMed ID: 14500565
    [Abstract] [Full Text] [Related]

  • 6. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.
    Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS.
    J Biol Chem; 2005 Mar 04; 280(9):7460-8. PubMed ID: 15615701
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of estrogenic/antiestrogenic activity of Onobrychis ebenoides extract - interaction with estrogen receptor subtypes ERalpha and ERbeta.
    Papoutsi Z, Kassi E, Halabalaki M, Mitakou S, Moutsatsou P.
    Toxicol In Vitro; 2007 Apr 04; 21(3):364-70. PubMed ID: 17092687
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 04; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens.
    Boué SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA, Cleveland TE.
    J Agric Food Chem; 2003 Apr 09; 51(8):2193-9. PubMed ID: 12670155
    [Abstract] [Full Text] [Related]

  • 11. Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media.
    Thomas PB, Risinger KE, Klinge CM.
    J Steroid Biochem Mol Biol; 2003 Jul 09; 86(1):41-55. PubMed ID: 12943744
    [Abstract] [Full Text] [Related]

  • 12. The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells.
    Klinge CM, Jernigan SC, Risinger KE.
    Endocrinology; 2002 Mar 09; 143(3):853-67. PubMed ID: 11861507
    [Abstract] [Full Text] [Related]

  • 13. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J.
    J Mol Endocrinol; 2004 Oct 09; 33(2):387-410. PubMed ID: 15525597
    [Abstract] [Full Text] [Related]

  • 14. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.
    Waffo-Téguo P, Hawthorne ME, Cuendet M, Mérillon JM, Kinghorn AD, Pezzuto JM, Mehta RG.
    Nutr Cancer; 2001 Oct 09; 40(2):173-9. PubMed ID: 11962253
    [Abstract] [Full Text] [Related]

  • 15. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM.
    Cancer Res; 2001 Oct 15; 61(20):7456-63. PubMed ID: 11606380
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
    Gehm BD, McAndrews JM, Chien PY, Jameson JL.
    Proc Natl Acad Sci U S A; 1997 Dec 09; 94(25):14138-43. PubMed ID: 9391166
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS, Bobseine K, Gray LE.
    Toxicol Sci; 2004 Sep 09; 81(1):69-77. PubMed ID: 15166400
    [Abstract] [Full Text] [Related]

  • 18. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct 09; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 19. Estrogenic properties of isoflavones derived from Millettia griffoniana.
    Wanda GJ, Njamen D, Yankep E, Fotsing MT, Fomum ZT, Wober J, Starcke S, Zierau O, Vollmer G.
    Phytomedicine; 2006 Feb 09; 13(3):139-45. PubMed ID: 16428019
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.